Addario Lung Cancer Medical Institute (ALCMI)

The Addario Lung Cancer Medical Institute (ALCMI, voiced as “Alchemy”), is an international consortium dedicated to catalyzing and accelerating the discovery, development and delivery of new and more effective treatment options for lung cancer patients.

ALCMI directly facilitates research by combining scientific expertise found at leading academic institutions with patient access through our network of community cancer centers – accelerating novel research advancements to lung cancer patients in partnership with diagnostics and bio-pharmaceutical companies.